Summary

for people ages 18 years and up (full criteria)
healthy people welcome
at La Jolla, California
study started
estimated completion:

Description

Summary

The purpose of this study is to collect information and bone marrow, blood, saliva, cheek cells and skin to be used in the laboratory to assist the sponsor in identifying a new way of treating MDS.

Official Title

Collection of Bone Marrow, Peripheral Blood (PB), Epithelial Tissue, and Saliva Samples From Patients With Myelodysplastic Syndromes (MDS) to Identify MDS-Specific Antigens (MSA) for Use in Cellular Immunotherapy.

Details

Goals of the study:

The purpose of this study is to collect the blood and marrow samples, and non-involved fibroblasts, that are required to identify the unique, personalized array of mutation-driven neoantigens that are expressed by the subject's MDS cells and to assess the feasibility of immunizing and expanding one or more of the patient's T cells ex vivo for investigation of their use as adoptive cellular immunotherapy.

Keywords

Myelodysplastic Syndromes(MDS) Syndrome Myelodysplastic Syndromes Preleukemia

Eligibility

For people ages 18 years and up

Patients must meet the following initial inclusion criteria:

  • Diagnosis or suspected diagnosis of MDS or CCUS
  • Age 18 or older

Patient exclusion criteria:

  • Currently receiving or within 3 months has received hypomethylating agent(s),lenalidomide, cytotoxic agents, or within the previous 4 weeks corticosteroids > 5 mg prednisone daily or any other immunosuppressants
  • Previous allogenic transplant
  • Inability to provide consent
  • Prisoners

Location

  • University of California San Diego accepting new patients
    La Jolla, California, 92093, United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
PersImmune, Inc
ID
NCT03072498
Lead Scientist
Rafael Bejar
Study Type
Observational
Last Updated
August 8, 2017